Drugs / TC-D101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07246304 | Nov 2025 → Nov 2027 expected | small cell lung carcinoma | TCRCure Biopharma Ltd. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TC-D101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07246304 ↗ |
| Modality | Cell therapy | “TC-D101 CAR-T cell therapy” NCT07246304 ↗ |